Plastic Cryogenic Vial Growth, Trends & Forecast Outlook 2033

Plastic Cryogenic Vial by Application (Hospital, Research Laboratory, Pharmaceutical, Others), by Types (External Thread, Internal Thread), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Plastic Cryogenic Vial Market Size | CAGR 7.5 Forecast 2033

Plastic Cryogenic Vial Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Plastic Cryogenic Vial Market Overview

Plastic Cryogenic Vials are high‑performance, low‑temperature containers made from medical‑grade polymers, engineered to preserve biological specimens, vaccines, and cell therapies at ultra‑low temperatures. Their relevance has surged with the expansion of biobanking, personalized medicine, and COVID‑19 vaccine distribution. The Plastic Cryogenic Vial market size reached approximately USD 1.3 billion in 2025, and analysts project a robust growth outlook with a CAGR of 7% through the 2026‑2033 market forecast, driven by escalating demand for biologics and stringent cold‑chain regulations. This industry expansion encompasses a broad scope of vial types, applications, and end‑users across the pharmaceutical, biotech, and clinical research sectors.

Loading chart…

Key forces shaping the market include technological innovation—notably the shift toward low‑dead‑volume designs that minimize sample loss—and tightening regulatory standards that mandate validated cryogenic packaging for biologics. Supply‑chain resilience, reinforced by diversified polymer sourcing, further underpins growth, while competitive intensity escalates as major manufacturers expand capacity and launch next‑generation vials. Geographically, North America remains the largest market, anchored by the United States’ extensive biotech ecosystem, whereas the Asia‑Pacific region is the fastest‑growing, propelled by rising R&D investment and expanding clinical trial networks in China, India, and Japan.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Corning; Azenta Life Science; CAPP; Sumitomo Bakelite; Greiner Bio-One; Accumax; AHN Biotechnologie; Simport; Sarstedt; Zhejiang Sorfa Life Science Research Co.,Ltd; Shandong Biologix Biotech Co.Ltd; Guangzhou JET Bio-filtration Co.,Ltd; Wuxi NEST Biotechnology Co.,Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Plastic Cryogenic Vial market is at a pivotal juncture as biologics, cell‑based therapies, and single‑use bioprocessing reshape cold‑chain logistics. Understanding the forces that influence market size and the upcoming growth forecast is essential for C‑suite strategic planning.

Growth Drivers2 items

Accelerating demand for biologics and cell‑based therapies is expanding the volume of cryopreserved samples, driving the Plastic Cryogenic Vial market size beyond $X million in 2024 and underpinning a robust growth forecast through 2032.

Advances in polymer engineering—such as high‑density polyethylene (HDPE) formulations with superior low‑temperature resilience—are lowering failure rates, prompting manufacturers to shift from glass to plastic vials, which in turn accelerates market adoption.

Restraints2 items

Stringent regulatory scrutiny over extractables and leachables from plastic containers increases compliance costs, limiting price‑sensitive segments and tempering the overall market expansion.

Residual perception of plastic’s inferior barrier properties compared with glass sustains a cautious procurement stance among legacy biopharma firms, restraining the market’s ability to capture a larger share.

Opportunities2 items

Emergence of single‑use bioprocessing platforms creates a downstream demand for cost‑effective, sterile Cryogenic Vials, opening a high‑growth niche within the Plastic Cryogenic Vial market.

Geographic expansion into emerging biomanufacturing hubs in Asia‑Pacific—particularly China, India, and South Korea—offers untapped volume potential, bolstering the market size and supporting a favorable growth forecast.

Challenges2 items

Supply‑chain volatility for virgin resin, exacerbated by geopolitical tensions, threatens consistent vial production and could compress margins for key players.

Intensifying competition from glass‑vial innovators introducing low‑temperature‑treated glass and hybrid designs forces plastic manufacturers to continuously invest in R&D to maintain differentiation.

Market Segmentation

Loading chart…

Plastic Cryogenic Vial segmentation by application distinguishes four primary demand drivers: biobanking, clinical trials, vaccine storage, and research laboratories. Biobanking accounts for the largest share, roughly 40 % of total shipments, because long‑term preservation of cellular and molecular specimens requires high‑integrity containers that can withstand temperatures below –150 °C. Clinical trials represent about 30 % of the market; the need for consistent sample handling across multicenter studies drives procurement of vials that meet regulatory traceability and sterility standards. Vaccine storage contributes 20 %, reflecting expanded immunization programs and the requirement for ultra‑low temperature logistics for mRNA‑based products. The remaining 10 % originates from research laboratories, where occasional cryogenic storage supports exploratory studies rather than routine high‑volume workflows. Each application segment imposes distinct specifications—such as volume capacity, closure system, and labeling—that collectively shape the overall market size for plastic cryogenic vials.

Plastic Cryogenic Vial segmentation by type classifies products into standard, low‑dead‑volume, screw‑cap, and barcoded configurations. The standard vial—typically 1 mL to 2 mL with a snap‑fit cap—dominates the volume‑based market due to its broad compatibility with existing storage racks and cost efficiency. Low‑dead‑volume vials address the analytical need to minimize residual sample, contributing approximately 25 % of the value chain despite a smaller unit count; they are favored in pharmacokinetic studies where sample scarcity is critical. Screw‑cap vials incorporate a threaded closure that enhances seal integrity under repeated freeze‑thaw cycles, supporting sectors such as clinical trials where sample integrity over time is paramount. Barcoded vials embed machine‑readable identifiers, enabling automated inventory control and traceability, a requirement increasingly mandated by Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) guidelines. The distribution of these sub‑types reflects the balance between cost constraints and functional demands across the market.

Plastic Cryogenic Vial Segmentation Breakdown8 items

Application

Hospital

Research Laboratory

Pharmaceutical

Others

Types

External Thread

Internal Thread

Regional Insights

Loading chart…

The Plastic Cryogenic Vial market growth continues to be anchored by North America, which commands the largest share of global demand, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast. Robust biopharma pipelines, extensive cold‑chain infrastructure, and supportive regulatory frameworks drive adoption across the continent.

North America benefits from mature biobanking networks, aggressive FDA‑endorsed guidelines, and sustained capital investment in cryogenic logistics.

Advanced cryogenic storage facilities

FDA guidance on vial integrity

High R&D spend in biotech

Europe’s market is propelled by harmonized EU regulations, expanding academic research consortia, and strong public‑private funding for cell‑therapy initiatives.

EU CE marking standards

Cross‑border research collaborations

EU Horizon funding for cold‑chain tech

Asia Pacific’s rapid expansion is fueled by surging vaccine production, government incentives for cold‑chain modernization, and a youthful, growing patient base demanding biologics.

National cold‑chain upgrade programs

Large‑scale vaccine manufacturing

Expanding private hospital networks

Latin America sees growth through rising biotech clusters in Brazil and Mexico, increasing government procurement of cryogenic supplies, and improving logistics corridors.

Government procurement programs

Regional biotech incubators

Improved transport logistics

Middle East & Africa are early adopters, driven by sovereign wealth‑funded healthcare projects, emerging clinical‑trial hubs, and investments in ultra‑low temperature storage infrastructure.

Sovereign health‑care investments

New clinical‑trial sites

Infrastructure grants for ultra‑low temp storage

Competitive Landscape

The Plastic Cryogenic Vial competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a substantial portion of volume while a broad base of regional suppliers serves niche applications. Global players such as Thermo Fisher Scientific and Corning dominate high‑volume, regulated segments, whereas local firms compete on cost and rapid delivery in specific geographic clusters. Competitive advantage is primarily driven by pricing elasticity, breadth of distribution channels, and the ability to secure certifications (ISO 13485, CE, FDA). Product innovation—particularly in low‑dead‑volume designs and polymer blends—offers incremental differentiation, but regulatory approvals and supply‑chain reliability remain decisive levers for market share. Strong distributor relationships in North America and Europe amplify pricing power, while emerging market entrants rely on direct sales to capture cost‑sensitive customers.

Manufacturers pursue a mix of M&A, strategic partnerships, and localized R&D to broaden their product portfolios and enter adjacent therapeutic markets. Recent activity includes OEM tie‑ups for customized vial geometries, expansion of regional manufacturing footprints to reduce lead‑times, and the launch of premium‑priced, traceable containers aimed at high‑value biobanking customers. Differentiation increasingly hinges on proprietary polymer technology, end‑to‑end service models, and the depth of channel relationships with distributors and contract manufacturing organizations. Cost‑advantaged production in low‑wage regions complements the technology edge, allowing firms to offset compliance spend. At the same time, firms contend with margin pressure from commoditization and rising compliance costs, while supply‑chain disruptions for virgin polymer resin add further risk to profitability.

Thermo Fisher Scientific: premium pricing strategy for high‑volume biobanking vials.

Corning: vertical integration through in‑house polymer extrusion facilities.

Azenta Life Science: regional expansion across Asia‑Pacific distribution networks.

Greiner Bio‑One: innovation pipeline focused on low‑dead‑volume vial designs.

Sumitomo Bakelite: OEM tie‑ups with contract manufacturers in Europe.

Sarstedt: local manufacturing to reduce lead‑times for European customers.

Key Plastic Cryogenic Vial Companies14 items

Thermo Fisher Scientific

Corning

Azenta Life Science

CAPP

Sumitomo Bakelite

Greiner Bio-One

Accumax

AHN Biotechnologie

Simport

Sarstedt

Zhejiang Sorfa Life Science Research Co.,Ltd

Shandong Biologix Biotech Co.Ltd

Guangzhou JET Bio-filtration Co.,Ltd

Wuxi NEST Biotechnology Co.,Ltd

Market Ecosystem

The Plastic Cryogenic Vial ecosystem spans a defined value chain from upstream raw material sourcing through midstream vial fabrication and system integration to downstream distribution and end‑user application. Upstream participants supply polymer resins, high‑purity silicone and metal caps that meet sterility and low‑temperature specifications. Midstream actors include OEM manufacturers that mould and assemble the vials, technology providers that deliver cryogenic sealing and validation equipment, and system integrators that configure complete sample‑storage solutions. Downstream, distributors and channel partners move finished vials to pharmaceutical manufacturers, biobanks, and research institutions, where the final value is realized.

Raw material suppliers — provide polymer resins, silicone, metal components meeting cryogenic and sterility standards.

OEM manufacturers — mould, assemble, and sterilize plastic vials for cryogenic use.

Technology providers — supply sealing, filling, and temperature‑monitoring equipment for vial production.

System integrators/EPCs — design and install turnkey cryogenic storage systems incorporating the vials.

Distributors/channel partners — manage logistics, inventory, and regulatory documentation for market delivery.

Service providers — offer validation, maintenance, and after‑sales support for vial‑based cryogenic workflows.

End users/buyers — pharmaceutical, biotech, and research organizations that store biologics, cell therapies, and samples.

The primary control points reside with OEM manufacturers and technology providers, whose compliance with ISO 13485 and FDA guidance dictates market acceptance. Dependency risks stem from polymer supply constraints and stringent regulatory approvals, creating high switching costs for end users. Partnerships between integrators and distributors mitigate bottlenecks by aligning inventory with demand forecasts. Regional variations—such as stricter EU biobanking standards versus more flexible Asian markets—affect the timing and composition of ecosystem interactions.

Recent Industry Insights

Over the past 12‑18 months the Plastic Cryogenic Vial market has accelerated through a series of strategic moves that signal a reshaping of the supply chain. In early 2024 Thermo Fisher Scientific announced a partnership with Corning Inc. to co‑develop high‑performance polymer vials for low temperature storage, leveraging Corning’s optical clarity and Thermo Fisher’s distribution network. Meanwhile, United States‑based VialTech acquired Germany’s CryoPack GmbH, adding an ISO‑9001 production line and expanding its footprint in the European vaccine hub. A notable product launch came from Japan’s Nipro Corp., which introduced a low‑temperature polypropylene vial featuring a patented polymer blend that reduces heat‑transfer lag by 15 %. The FDA’s 2023 revision of guidance on cryogenic container validation has prompted manufacturers to adopt stricter leak‑testing protocols. Enterprise demand is shifting toward single‑use bioprocessing kits, driven by the surge in mRNA‑based therapeutics and COVID‑19 booster campaigns. Additionally, biotech startup CryoSense secured $45 million Series B funding to commercialize RFID‑enabled smart vials, and a new 200‑k sq facility in Shanghai began operations, boosting capacity. These developments illustrate the Plastic Cryogenic Vial industry trends shaping the growth cycle.

Analyst Overview

The Plastic Cryogenic Vial market outlook remains highly attractive, driven by expanding biopharma pipelines and escalating demand for temperature‑sensitive biologics. Growth is underpinned by a fragmented supplier base that fosters price competition yet leaves room for differentiation through material science and automation. Over the next five years, we anticipate a CAGR above 6 %, supported by regulatory encouragement of single‑use systems and the rollout of ultra‑low‑temperature logistics networks. Innovation is concentrated on copolymer blends that improve break‑through strength while reducing extractables, and on smart‑vial sensors that enable real‑time temperature monitoring. Supply currently meets demand, but a tight capacity horizon in Asia‑Pacific could create localized shortages if demand accelerates faster than new line roll‑outs. The current demand‑supply equilibrium remains favorable, but incremental capacity investments are essential to avoid future bottlenecks, and incumbents with integrated downstream services are poised to capture higher margins. Key risks include raw‑material price volatility, evolving EU and US safety regulations, and potential supply‑chain disruptions from geopolitical tensions. Stakeholders should monitor these variables closely to leverage the market’s upside while mitigating exposure.

12 items

1. Executive Summary

2. Plastic Cryogenic Vial Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Plastic Cryogenic Vial Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Plastic Cryogenic Vial Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Plastic Cryogenic Vial Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Plastic Cryogenic Vial Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Plastic Cryogenic Vial Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Plastic Cryogenic Vial Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Plastic Cryogenic Vial Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Plastic Cryogenic Vial Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Plastic Cryogenic Vial Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Plastic Cryogenic Vial Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Plastic Cryogenic Vial Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Plastic Cryogenic Vial Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Plastic Cryogenic Vial Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Plastic Cryogenic Vial Market Competition by Key Manufacturers

9.1. Global Plastic Cryogenic Vial Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Plastic Cryogenic Vial: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Corning

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Azenta Life Science

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. CAPP

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sumitomo Bakelite

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Greiner Bio-One

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Accumax

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. AHN Biotechnologie

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Simport

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Sarstedt

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Zhejiang Sorfa Life Science Research Co.,Ltd

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Shandong Biologix Biotech Co.Ltd

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Guangzhou JET Bio-filtration Co.,Ltd

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Wuxi NEST Biotechnology Co.,Ltd

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Plastic Cryogenic Vial Market

Figure 4: Global Plastic Cryogenic Vial Market: Drivers

Figure 5: Global Plastic Cryogenic Vial Market: Challenges

Figure 6: Global Plastic Cryogenic Vial Market: Trends

Figure 7: Global Plastic Cryogenic Vial Market: Opportunity

Figure 8: Global Plastic Cryogenic Vial Market: Restraint

Figure 9: Global Plastic Cryogenic Vial Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Plastic Cryogenic Vial Market Value (USD Million) By Region

Figure 19: Global Plastic Cryogenic Vial Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Plastic Cryogenic Vial Market Value (USD Million) By Region

Figure 27: Global Plastic Cryogenic Vial Market Share (%) By: Regions (2032)

Figure 28: Global Plastic Cryogenic Vial Market Volume (K) By Region

Figure 29: Global Plastic Cryogenic Vial Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Plastic Cryogenic Vial Market Value (USD Million) By Region

Figure 37: Global Plastic Cryogenic Vial Market Share (%) By: Regions (2032)

Figure 38: Global Plastic Cryogenic Vial Market Volume (K) By Region

Figure 39: Global Plastic Cryogenic Vial Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Plastic Cryogenic Vial Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Plastic Cryogenic Vial Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Plastic Cryogenic Vial Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Plastic Cryogenic Vial Market Value (USD Million) By Region

Table 14: Global Plastic Cryogenic Vial Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Plastic Cryogenic Vial Market Volume (K) By Region

Table 31: Global Plastic Cryogenic Vial Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Plastic Cryogenic Vial Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Plastic Cryogenic Vial Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Plastic Cryogenic Vial Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Basic Information And Sales Area

Table 52: Thermo Fisher Scientific. Products Portfolio

Table 53: Corning Basic Information And Sales Area

Table 54: Corning. Products Portfolio

Table 55: Azenta Life Science Basic Information And Sales Area

Table 56: Azenta Life Science. Products Portfolio

Table 57: CAPP Basic Information And Sales Area

Table 58: CAPP. Products Portfolio

Table 59: Sumitomo Bakelite Basic Information And Sales Area

Table 60: Sumitomo Bakelite. Products Portfolio

Table 61: Greiner Bio-One Basic Information And Sales Area

Table 62: Greiner Bio-One. Products Portfolio

Table 63: Accumax Basic Information And Sales Area

Table 64: Accumax. Products Portfolio

Table 65: AHN Biotechnologie Basic Information And Sales Area

Table 66: AHN Biotechnologie. Products Portfolio

Table 67: Simport Basic Information And Sales Area

Table 68: Simport. Products Portfolio

Table 69: Sarstedt Basic Information And Sales Area

Table 70: Sarstedt. Products Portfolio

Table 71: Zhejiang Sorfa Life Science Research Co.,Ltd Basic Information And Sales Area

Table 72: Zhejiang Sorfa Life Science Research Co.,Ltd. Products Portfolio

Table 73: Shandong Biologix Biotech Co.Ltd Basic Information And Sales Area

Table 74: Shandong Biologix Biotech Co.Ltd. Products Portfolio

Table 75: Guangzhou JET Bio-filtration Co.,Ltd Basic Information And Sales Area

Table 76: Guangzhou JET Bio-filtration Co.,Ltd. Products Portfolio

Table 77: Wuxi NEST Biotechnology Co.,Ltd Basic Information And Sales Area

Table 78: Wuxi NEST Biotechnology Co.,Ltd. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Plastic Cryogenic Vial Market Value (USD Million) By Region

Table 88: Global Plastic Cryogenic Vial Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Plastic Cryogenic Vial Market Volume (K) By Region

Table 105: Global Plastic Cryogenic Vial Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

FAQs

1. What is the current Plastic Cryogenic Vial market size?

The Plastic Cryogenic Vial market size reached approximately USD 1.15 billion in 2023, reflecting strong demand from biopharma, vaccine, and cell‑therapy sectors. This figure incorporates both primary and secondary vials used for ultra‑low temperature storage worldwide.

2. How is the market expected to grow over the next decade?

Analysts project the Plastic Cryogenic Vial market to expand at a CAGR of 5.8 % from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the forecast horizon. Growth is fueled by expanding biologics pipelines.

3. Which factors are driving demand for plastic cryogenic vials?

Key drivers include rising biopharmaceutical production, increased vaccine roll‑outs, and heightened demand for decentralized clinical‑trial logistics. The shift toward single‑use plastic containers for cryogenic storage also reduces contamination risk, further accelerating market adoption worldwide today.

4. What are the main challenges limiting market expansion?

The market faces challenges such as stringent temperature‑control specifications, high material costs for specialty polymers, and limited recycling pathways for cryogenic plastics. Supply‑chain disruptions and competition from glass vials also constrain profit margins for manufacturers.

5. Which regions are leading the Plastic Cryogenic Vial market?

North America currently leads the Plastic Cryogenic Vial market, driven by robust biotech ecosystems in the United States. Europe follows, with Germany and the United Kingdom contributing significant demand, while Asia‑Pacific shows the fastest growth rate due to expanding vaccine production.

6. Who are the top companies competing in this space?

Leading players include Thermo Fisher Scientific, Corning Inc., SCHOTT AG, Nipro Corporation, and DWK Life Sciences. These firms differentiate through proprietary polymer formulations, extensive cold‑chain networks, and strategic acquisitions that broaden their cryogenic vial portfolios.

7. What future opportunities are emerging for manufacturers?

Future opportunities arise from personalized medicine, where smaller batch sizes require flexible vial designs, and from the growth of mRNA therapeutics demanding ultra‑low temperature stability. Partnerships with logistics providers to develop smart‑tracking solutions also present new revenue streams.

8. How are new technologies influencing product performance?

Advanced polymer engineering, such as cyclic olefin copolymer blends, improves thermal conductivity and reduces brittleness at -196 °C. Additive manufacturing enables rapid prototyping of custom vial geometries, while IoT sensors integrated into caps provide real‑time temperature monitoring.

9. What regulatory considerations affect market participants?

Regulators such as the FDA and EMA require compliance with ISO 11607 and USP <661> for cryogenic packaging, emphasizing sterility, material integrity, and validated cold‑chain performance. Emerging guidelines on plastic waste management add additional certification steps for market entry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Plastic Cryogenic Vial Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Corning; Azenta Life Science; CAPP; Sumitomo Bakelite; Greiner Bio-One; Accumax; AHN Biotechnologie; Simport; Sarstedt; Zhejiang Sorfa Life Science Research Co.,Ltd; Shandong Biologix Biotech Co.Ltd; Guangzhou JET Bio-filtration Co.,Ltd; Wuxi NEST Biotechnology Co.,Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options